Drug Profile
Research programme: anti-gastrin antibodies - Aphton Corporation/XOMA
Latest Information Update: 05 Nov 2009
Price :
$50
*
At a glance
- Originator Aphton Corporation; XOMA
- Class Monoclonal antibodies
- Mechanism of Action Gastrin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Gastrointestinal cancer
Most Recent Events
- 05 Nov 2009 Discontinued - Preclinical for Gastrointestinal cancer in USA (unspecified route)
- 28 Sep 2004 Preclinical trials in Gastrointestinal cancer in USA (unspecified route)